文献速递腹部MR

根据MRI特征评估2级胰腺神经内分泌肿瘤中Ki-67指数的过宽范围

Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

本研究以Ki-67指数5%为界值,回顾分析41例2级胰腺神经内分泌肿瘤的术前MRI特征,发现Ki-67≥5%组更常表现为实性、延迟期包膜样强化不完整及肝或淋巴结转移,ADC比值更低且为独立鉴别指标,最佳界值1.25×10-3(敏感度96.3%,特异度62.5%)。

要点

  • ADC比值是鉴别2级胰腺神经内分泌肿瘤Ki-67<5%与≥5%的独立指标,AUROC为0.816±0.07。
  • Ki-67≥5%组更常出现实性、延迟期包膜样强化不完整及肝或淋巴结转移。
  • 预测Ki-67≥5%的最佳ADC比值界值为1.25×10-3,敏感度96.3%、特异度62.5%。

核心结论

  • MRI特征可能识别2级胰腺神经内分泌肿瘤的过宽范围,并有助于预测Ki-67值,作为肿瘤侵袭性的替代指标;预测Ki-67状态(≥/<5%)的最佳ADC比值界值为1.25×10-3。

研究设计与样本

  • 回顾性纳入2010年1月至2016年10月间41例2级胰腺神经内分泌肿瘤患者(1例患者有3个肿瘤),均有术前MRI;肿瘤分级依据2016年修订版世界卫生组织胰腺神经内分泌肿瘤分类。

关键影像表现/征象

  • Ki-67≥5%组较<5%组更常表现为实性(85% vs. 50%,P<0.05)。
  • Ki-67≥5%组较<5%组更常表现为延迟期包膜样强化不完整(74% vs. 62%,P<0.05)。
  • Ki-67≥5%组较<5%组更常出现肝或淋巴结转移(67% vs. 31%,P<0.05)。
  • Ki-67≥5%组ADC比值小于<5%组(0.85±0.23 vs. 1.29±0.39,P=0.001)。

诊断标准与关键数值

  • 以Ki-67指数5%为界值,将2级胰腺神经内分泌肿瘤分为Ki-67<5%组(16个肿瘤,37.2%)与Ki-67≥5%组(27个肿瘤,62.8%)。
  • ADC比值(肿瘤/正常胰腺实质)鉴别Ki-67<5%与≥5%的AUROC为0.816±0.07。
  • 预测Ki-67≥5%的最佳ADC比值界值为1.25×10-3,敏感度96.3%,特异度62.5%。

临床应用与阅片要点

  • 阅片时可关注肿瘤实性成分、延迟期包膜样强化完整性及肝或淋巴结转移,这些特征在Ki-67≥5%的2级胰腺神经内分泌肿瘤中更常见。
  • 测量ADC比值(肿瘤/正常胰腺实质)有助于预测2级胰腺神经内分泌肿瘤的Ki-67状态,界值1.25×10-3提示Ki-67≥5%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the value of MR imaging features in stratifying Grade 2 (G2) pancreatic neuroendocrine tumors (PNETs) using the 5% cut-off value of the Ki-67 index as reference standards.

MATERIALS AND METHODS: Between January 2010 and October 2016, 41 G2 PNET patients (One patient had 3 tumors) with preoperative MR imaging were included. Tumor grading was based on the revised 2016 World Health Organization classification of PNETs. MR imaging features included size, shape, consistency, T1-w and T2-w signal intensities, enhancement pattern, apparent diffusion coefficient (ADC) ratios (tumor/normal pancreatic parenchyma).

RESULTS: 16 Ki-67 index < 5% tumors (SKIT, 37.2%) and 27 Ki-67 index ≥ 5% tumors (LKIT, 62.8%) of G2 were evaluated. The LKIT showed solid consistency (85% vs. 50%, P < 0.05), incomplete envelope-like reinforcement in a delayed phase (74% vs. 62%, P < 0.05), and liver or lymph node metastases (67% vs. 31%, P < 0.05) more frequently than did SKIT. However, ADC ratios of LKIT were smaller than SKIT (0.85 ± 0.23 vs. 1.29 ± 0.39, P = 0.001). Using binary logistic regression analysis, the ADC ratio was an independent significant differentiator of SKIT from LKIT. The AUROC of ADC ratios was 0.816 ± 0.07. The optimal cut-off value for the identification of LKIT was 1.25 × 10-3 (sensitivity 96.3%, specificity 62.5%).

CONCLUSION: MRI features may identify the overbroad scope of G2 PNETs and help predict Ki-67 values, as a surrogate for tumor aggressiveness, in G2 PNETs. An optimal cut-off value for predicting Ki-67 status (≥/< 5%) was 1.25 × 10-3 of ADC ratio.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hu Y, Rao S, Xu X, et al. Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features. Abdom Radiol (NY). 2018. PMID: 29619528. doi:10.1007/s00261-018-1573-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。